| Solid Neoplasm studied in …STUDIED_INderived10 of 6,088show all (up to 200) |
|---|
| → studied in | NCT00591383Phase 1 · completed Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00592163Phase 1 · completed Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00726687Phase 1/Phase 2 · completed Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01340547Phase 1 · completed Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02498912Phase 1 · active not recruiting Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03707808Phase 1/Phase 2 · active not recruiting Intratumoral Injection of Autologous CD1c (BDCA-1)+ myDC, AS01B, and Ipilimumab Plus Systemic Nivolumab · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03837899Phase 1/Phase 2 · active not recruiting Durvalumab and Tremelimumab for Pediatric Malignancies · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03842228Phase 1 · active not recruiting Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04111458Phase 1 · active not recruiting A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation) · condition mapped CURATED_BROADER · 6,088 trials mapped (1,991 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |